Targeting ERK and mTOR for the treatment of fragile X syndrome

Osterweil, Emily (Principal Investigator)

Status	Finished
Effective start/end date	1/12/14 → 31/12/18

Funding

MRC: £569,732.00

1 Article
1 Literature review

Cell-type-specific translation profiling reveals a novel strategy for treating fragile X syndrome
Thomson, S. R., Seo, S. S., Barnes, S. A., Louros, S. R., Muscas, M., Dando, O., Kirby, C., Wyllie, D. J. A., Hardingham, G. E., Kind, P. C. & Osterweil, E. K., 2 Aug 2017, In: Neuron. 95, 3, p. 550-563.e5 19 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Perturbed proteostasis in autism spectrum disorders
Louros, S. R. & Osterweil, E. K., 1 Jul 2016, (E-pub ahead of print) In: Journal of Neurochemistry.
Research output: Contribution to journal › Literature review › peer-review

Open Access
File